sb 203580 has been researched along with phloroglucinol in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (phloroglucinol) | Trials (phloroglucinol) | Recent Studies (post-2010) (phloroglucinol) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,775 | 40 | 876 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feisst, C; Glaubitz, C; Hoffmann, M; Jakobsson, PJ; Lopez, JJ; Pawelczik, S; Pergola, C; Sorg, BL; Steinhilber, D; Werz, O | 1 |
1 other study(ies) available for sb 203580 and phloroglucinol
Article | Year |
---|---|
Hyperforin induces Ca(2+)-independent arachidonic acid release in human platelets by facilitating cytosolic phospholipase A(2) activation through select phospholipid interactions.
Topics: Arachidonic Acid; Blood Platelets; Bridged Bicyclo Compounds; Calcium; Cytosol; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Magnetic Resonance Spectroscopy; p38 Mitogen-Activated Protein Kinases; Phloroglucinol; Phosphatidylcholines; Phospholipases A2; Phosphorylation; Pyridines; Terpenes | 2010 |